Abstract
Essential hypertension (blood pressure > 160/95 mmHg) is a common disorder that affects approximately 15–20% of Caucasian populations [1]. If a blood pressure greater than 140/90 mmHg is used as the cut off value, then 40–45 % of the general population would be considered to have essential hypertension [1]. In nonwhite populations the incidence of essential hypertension is even higher. A number of factors including obesity, physical inactivity, age, dyslipidemia, glucose intolerance, smoking, and positive family history all have been linked to an increased incidence of essential hypertension. It is noteworthy that each one of these factors has been shown to be associated with the presence of insulin resistance [2–8]. Conversely, weight loss [9] and enhanced physical activity [10] have been shown to improve insulin sensitivity and to lower blood pressure.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kannel WB, Schwartz MJ, McNamara PM. Blood pressure and risk of coronary heart disease: the Framingham study. Dis Chest 1969; 56: 43–52.
Golay A, Felber JP, Jequier E, DeFronzo RA, Ferrannini E. Metabolic basis of obesity and non-insulin dependent diabetes mellitus. Diabetes Metab Rev 1988; 4: 727–747.
Schneider SH, Vitug A, Ruderman N. Atherosclerosis and physical activity Diabetes Metab Rev 1986; 1: 513–553.
DeFronzo RA. Glucose intolerance and aging. Diabetes Care 1981; 4: 483–501.
Garg A, Helderman JH, Koffler M. Aguro R, Rosenstock J, Raskin P. Relationship between lipoprotein levels and in vivo insulin action in normal young white men. Metabolism 1988; 37: 982–987.
DeFronzo RA. Lilly lecture. The triumvirate: beta cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988; 37: 667–687.
Attvall S, Fowelin J, Later I, Smith U. Smoking induces insulin resistance syndrome. J Intern Med 1994; in press.
Williams RR, Hunt SC, Huida H, Smith JB, Ash KO. Sodium-lithium countertransport in erythrocytes of hypertension prone families in Utah. Am J Epidemiol 1983; 11: 338–344.
Henry RR, Scheaffer L, Olefsky JM. Glycemic effects of intensive caloric restriction and isocaloric refeeding in NIDDM. J Clin Endocrinol Metab 1985; 61: 917–925.
Koivisto V, DeFronzo RA. Physical training and insulin sensitivity. Diabetes Metab Rev 1986; 1: 445–481.
DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovasculardisease. Diabetes Care 1991; 14: 173–194.
DeFronzo RA. Insulin resistance, hyperinsulinemia and coronary artery disease: a complex metabolic web. Coronary Art Dis 1992; 3: 11–25.
Reaven GM. Banting lecture. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–1607.
Ferrannini E, Haffner SM, Mitchell BD, Stern HP. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991; 34: 416–422.
Mogensen CE, Hansen KW, Mau Pedersen M, Christensen CK. Renal factors influencing blood pressure threshold and choice of treatment for hypertension in IDDM. Diabetes Care 1991; 14: suppl. 4: 13–26.
DeFronzo RA. Incipient diabetic nephropathy: etiologic and therapeutic considerations. A monograph. Pawling, NY: Caduceus Medical Publishers; 1993; pp. 1–30.
Mogensen CE, Christensen CK. Blood pressure changes and renal function changes in incipient and overt diabetic nephropathy. Hypertension 1985; 7: suppl. II: II-64–II-73.
A Multicenter Study. United Kingdom Prospective Diabetes Study. III. Prevalence of hypertension and hypotensive therapy in patients with newly diagnosed diabetes. Hypertension 1985; 7: suppl. II: II-8–II-13.
Trevisan R, Nosadini R, Fioretto P, Semplicini A, Donadon V, Doria A, Nicolosi G, Zanuttini D, Cipollina MR, Lusiani L, Avogaro A, Crepaldi G, Viberti GC. Clustering of risk factors in hypertensive insulin-dependent diabetics with high sodium-lithium countertransport. Kidney Int 1992; 41: 855–861.
Matlock MB, Morrish NJ, Viberti GC, Keen H, Fitzgerald AP, Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992; 41: 736–741.
Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989; 32: 219–226.
Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992; 41: 715–722.
DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 1992; 15: 318–368.
Manicardi V, Camellini L, Bellodi G, Coscelli C, Ferrannini E. Evidence for an association of high blood pressure and hyperinsulinaemia in obese man. J Clin Endocrinol Metab 1986; 62: 1302–1304.
Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350–357.
Pollare T, Lithell H, Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 1990; 39: 167–174.
Laakso M, Sarlund H, Mylkkkanen L. Essential hypertension and insulin resistance in non insulin dependent diabetes. Eur J Clin Invest 1989; 19: 518–526.
Natali A, Santoro D, Palombo C, Cerri M, Ghione S, Ferrannini E. Impaired insulin action on skeletal muscle metabolism in essential hypertension. Hypertension 1991; 17: 170–178.
Capaldo B, Lembo G, Napoli R, Rendina V, Albano G, Sacca L, Trimarco B. Skeletal muscle is a primary site of insulin resistance in essential hypertension. Metabolism 1991; 40: 1320–1322.
Brands MW, Hilderbrandt DA, Mizelle HL, Hall JE. Sustained hyperinsulinemia increases arterial pressure in conscious rats. Am J Physiol 1991; 260: R764-R768.
Hall JE, Coleman TG, Mizell HL, Smith Jr. MJ. Chronic hyperinsulinemia and blood pressure regulation. Am J Physiol 1990; 258: F722-F731.
Randeree HA, Omar MA, Motala AA, Seedat MA. Effect of insulin therapy on blood pressure in NIDDM patients with secondary failure. Diabetes Care 1992; 15: 1258–1263.
Tedde R, Sechi LA, Marigliano A, Pala A, Scano L. Antihypertensive effect of insulin reduction in diabetic-hypertensive patients. Am J Hypertens 1989; 2: 163–170.
Landin K, Tengborn L. Smith U. Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors. J Intern Med 1991; 229: 181–187.
Muller DC, Elahi D, Pratley RE, Tobin JD, Andres R. An Epidemiological Test of the Hyperinsulinemia- Hypertension Hypothesis. J Clin Endocrinol Metab 1993; 76: 544–548.
Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; i: 7825–7829.
DeFronzo RA, Cooke CR, Andres R, Faloona GR, Davis PJ. The effects of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest 1975; 55: 845–855.
Trevisan R, Fioretto P, Semplicini A, Opocher G, Mantero F, Rocco S, Remuzzi G, Morocutti A, Zanette G, Donadon V, Perico N, Giorato C, Nosadini R. Role of insulin and atrial natriuretic peptide in sodium retention in insulin-treated IDDM patients during isotonic volume expansion. Diabetes 1990; 39: 289–298.
DeFronzo RA, Goldberg M, Agus ZS. The effects of glucose and insulin on renal electrolyte transport. J Clin Invest 1976; 58: 83–90.
Baum M. Insulin stimulates volume absorption in the proximal convoluted tubule. J Clin Invest 1987; 79: 1104–1109.
Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 1981; 30: 219–225.
Fioretto P, Muollo B, Faronato PP, Opocher G, Trevisan R, Tiengo A, Mantero F, Remuzzi G, Crepaldi G, Nosadini R. Relationship among natriuresis, atrial natriuretic peptide and insulin in insulin-dependent diabetes. Kidney Int 1992; 41: 813–821.
Weidmann P, Beretta-Picolli C, Trost BN. Pressor factors and responsiveness in hypertension accompanying diabetes mellitus. Hypertension 1985; 7: suppl. II: 33–42
Weidmann P, Ferrari P. Central role of sodium in hypertension in diabetic subjects. Diabetes Care 1991; 14: 220–232.
Daly PA, Landsberg L. Hypertension in obesity and NIDDM: role of insulin and sympathetic nervous system. Diabetes Care 1991; 14: 240–248.
Anderson EA, Hoffmann RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 1991; 87: 2246–2252.
Julius S. Autonomic nervous dysfunction in essential hypertension. Diabetes Care 1991; 14: 249–259.
Diebert DC, DeFronzo RA. Epinephrine-induced insulin resistance in man: a beta receptor mediated phenomenon. J Clin Invest 1980; 65: 717–721.
Ortola FV, Ballerman BJ, Anderson S, Mendez RE, Brenner BM. Elevated plasma atrial natriuretic peptide levels in diabetic rats. J Clin Invest 1987; 80: 670–674.
Nosadini R, Fioretto P, Trevisan R, Crepaldi G. Insulin-dependent diabetes mellitus and hypertension. Diabetes Care 1991; 14: 210–219.
Moore RD, Gupta RK. Effect of insulin on intracellular pH as observed by phosphorus31 NMR spectroscopy. Int J Quantum Chem Symp 1986; 7: 83–92.
Moore RD. Stimulation of Na:H exchange by insulin. Biophys J 1981; 33: 203–210.
Putnam RW. Effect of insulin on intracellular pH in frog skeletal muscle fibers. Am J Physiol 1985; 248: C330–336.
Lever AF. Slow pressor mechanisms in hypertension: a role for hypertrophy of resistance vessels. J Hypertens 1986; 4: 515–524.
Boon NA, Harper C, Aranson JK, Grahame-Smith DG. Cation transport functions in vitro in patients with untreated essential hypertension: a comparison of erythrocytes and leucocytes. Clin Sci 1985; 68: 511–515.
Woods JW, Falk RJ, Pittman AW, Klemmer PJ, Watson BS, Namboodiri K. Increased red-cell sodium-lithium countertransport in normotensive sons of hypertensive parents. N Engl J Med 1982; 306: 593–595.
Mangili R, Bending JJ, Scott G, Li LK, Gupta A, Viberti GC. Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy. N Engl J Med 1988; 318: 146–150.
Fioretto P, Trevisan R, Doria A, Avogaro A, Semplicini A, Donadon V, Abbruzzese E, Crepaldi G, Viberti GC, Nosadini R. High sodium-lithium countertransport activity in red blood cells is associated with insulin resistance and cardiac and renal hypertrophy in insulin dependent diabetes before the onset of nephropathy. Diabetologia 1990; 33: 6.
Resnick LM. Calcium metabolism in hypertension and allied metabolic disorders. Diabetes Care 1991; 14: 505–520.
Sowers JR, Zemel MB. Clinical implications of hypertension in the diabetic patient. Am J Hypertens 1990; 3: 415–424.
Draznin B, Sussman KE, Eckel RH, Kao M, Yost T, Sherman NA. Possible role of cytosolic free calcium concentrations in mediating insulin resistance of obesity and hyperinsulinemia. J Clin Invest 1988; 28: 1848–1852.
Levy J, Gavin JR, Hammerman MR, Avioli LV. Ca++ +Mg++-ATPase activity in kidney basolaterol membrane in non-insulin dependent diabetic rats. Effect of insulin. Diabetes 1987; 35: 899–905.
Yagi S, Takata S, Kiyokawa H, Yamamoto M, Noto Y, Ikeda T, Hattori N. Effects of insulin on vasoconstrictive responses to norepinephrine and angiotensin II in rabbit femoral artery and vein. Diabetes 1988; 37: 1064–1067.
Draznin B, Kao M, Sussman KE. Insulin and glyburide increase cystolic free calcium concentration in isolated rat adipocytes. Diabetes 1987; 36: 174–178.
DeFronzo RA. Clinical disorders of hyperkalemia. In: Seldin D, Giebisch G (eds). The Kidney: Physiology and Pathophysiology. New York: Raven Press; 1991; pp. 1179–1206.
Linas SL. The role of potassium in the pathogenesis and treatment of hypertension. Kidney Int 1991; 39: 771–786.
Hilton PJ. Na + transport in hypertension. Diabetes Care 1991; 14: 233–239.
Cullen K, Stenhouse NS, Wearne KL, Welborn TA. Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia — 13 year study. J Chronic Dis 1983; 36: 371–377.
Fontbonne A, Charles MA, Thibult N, Richard JL, Claude JR, Warnet JM, Rosselin GE, Eschwege E. Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up. Diabetologia 1991; 34: 356–361.
Pyörälä K, Savolainen E, Kaukola S, Haapakoski J. Plasma insulin and coronary heart disease risk factor relationship to other risk factors and predictive value during 91/2-year follow-up of the Helsinki Policemen Study population. Acta Med Scand 1985; suppl. 701: 38–52.
Turner RC, United Kingdom prospective diabetes study. III. Prevalence of hypertension and hypotensive therapy in patients with newly diagnosed diabetes. Hypertension 1985; 7: suppl. II: 8–13.
Stout RW. Insulin as a mitogenic factor: role in the pathogenesis of cardiovascular disease. Am J Med 1991; 90: 62S–65S.
Cruz AB, Amatuzio DS, Grande F, Hay LJ. Effect of intraarterial insulin on tissue cholesterol and fatty acids in alloxan-diabetic dogs. Circ Res 1961; 9: 39–43.
Duff GL, McMillan GC. The effect of alloxan diabetes on experimental cholesterol atherosclerosis in the rabbit. I. The inhibition of experimental cholesterol atherosclerosis in alloxan diabetes. II. The effect of alloxan diabetes on the retrogression of experimental cholesterol atherosclerosis. J Exp Med 1949; 89: 611–629.
Bressler P, Bailey S, Saad R, DeFronzo RD. Insulin resistance and coronary artery disease: the missing link. Diabetes 1991; 41: suppl. 1: 24A.
Krolewski AS, Warram JH, Valsania P, Martin BC, Laffel L, Christlieb R. Evolving natural history of coronary artery disease in diabetes mellitus. Am J Med 1991; 90: suppl. 2A: 565–615.
Castellino P, Shohat J, DeFronzo RA. Hyperfiltration and diabetic nephropathy. Is it the beginning? Or is it the end? Sem Nephrol 1990; 10: 228–241.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Solini, A., Defronzo, R.A. (1994). Hypertension, Cardiovascular Disease, Diabetes Mellitus, and Diabetic Nephropathy: Role of Insulin Resistance. In: Mogensen, C.E. (eds) The Kidney and Hypertension in Diabetes Mellitus. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6746-9_4
Download citation
DOI: https://doi.org/10.1007/978-1-4757-6746-9_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-6748-3
Online ISBN: 978-1-4757-6746-9
eBook Packages: Springer Book Archive